|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/08 | (2006.01) |
| A61P 13/12 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 7/06 | (2006.01) |
| (11) | Number of the document | 2717896 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12728907.2 |
| Date of filing the European patent application | 2012-06-08 | |
| (97) | Date of publication of the European application | 2014-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-24 |
| (46) | Date of publication of the claims translation | 2017-02-27 |
| (86) | Number | PCT/US2012/041759 |
| Date | 2012-06-08 |
| (87) | Number | WO 2012/170955 |
| Date | 2012-12-13 |
| (30) | Number | Date | Country code |
| 201161494874 P | 2011-06-08 | US |
| (72) |
KARIM, Felix, US
BELL, Gregory, US
|
| (73) |
Kai Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Terapiniai agentai, skirti fosforo koncentracijos serume reguliavimui |
| THERAPEUTIC AGENTS FOR REGULATING SERUM PHOSPHORUS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 14 | 289.00 EUR |
| 2026-06-08 |